Report Detail

Request for Sample of this report

Pharma & Healthcare Global Paclitaxel Injection Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM2995809
    • |
  • 21 February, 2019
    • |
  • Global
    • |
  • 124 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

Paclitaxel Injection is a kind of anti-cancer injection taking paclitaxel API as raw material. It is mainly used in breast cancer, ovarian cancer and other cancers.
Paclitaxel injection comes as a liquid to be given intravenously (into a vein) by a doctor or nurse in a hospital or clinic. It is usually given once every 3 weeks. When paclitaxel injection manufactured with polyoxyethylated castor oil is used to treat Kaposi's sarcoma, it may be given once every 2 or 3 weeks.

Scope of the Report:
In recent years, the growing population and increasing disease incidence of ovarian cancer, breast cancer and other cancers drive the global paclitaxel injection industry developing.

In the past five years from 2010-2014, global paclitaxel injection industry developed fast with a larger than 15% annual production growth rate. In China, due to the late start, the production growth rate is 12%~17%, which is a little lower than global average.

In the next few years, with the growing attention on women cancers from the whole society and much larger investment on R&D of paclitaxel injection, this industry will continue developing at a high speed. What’s more, because of the high gross profit of producing and selling paclitaxel injection, more and more investors will enter into this industry.

At present, the production of paclitaxel injection mainly concentrated in US, China and EU, the three regions produced about 77.30% of the global total products. Of those, US are the largest production region with a 42.69% of global production market share.

In the future, with the expanded capacity of paclitaxel injection, the manufacturers will face the high risk of price and gross margin decline.

The worldwide market for Paclitaxel Injection is expected to grow at a CAGR of roughly 11.0% over the next five years, will reach 3680 million US$ in 2024, from 2180 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Paclitaxel Injection in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Bristol-Myers Squibb
Celgene Corporation
Hospira
Biological E.
Taj Accura
Khandelwal Laboratories
Luye Pharma
Beijing Youcare
Beijing Union
Haiyao
Chuntch

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Drug Strength
Raw meterial Paclitaxel API source

Market Segment by Applications, can be divided into
Ovarian cancer
Breast cancer
Cervical cancer
Pancreatic cancer
Other

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Paclitaxel Injection product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Paclitaxel Injection, with price, sales, revenue and global market share of Paclitaxel Injection in 2017 and 2018.
Chapter 3, the Paclitaxel Injection competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Paclitaxel Injection breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Paclitaxel Injection market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Paclitaxel Injection sales channel, distributors, customers, research findings and conclusion, appendix and data source.


Table of Contents

    1 Market Overview

    • 1.1 Paclitaxel Injection Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Drug Strength
      • 1.2.2 Raw meterial Paclitaxel API source
    • 1.3 Market Analysis by Applications
      • 1.3.1 Ovarian cancer
      • 1.3.2 Breast cancer
      • 1.3.3 Cervical cancer
      • 1.3.4 Pancreatic cancer
      • 1.3.5 Other
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Bristol-Myers Squibb
      • 2.1.1 Business Overview
      • 2.1.2 Paclitaxel Injection Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Bristol-Myers Squibb Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Celgene Corporation
      • 2.2.1 Business Overview
      • 2.2.2 Paclitaxel Injection Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Celgene Corporation Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Hospira
      • 2.3.1 Business Overview
      • 2.3.2 Paclitaxel Injection Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Hospira Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Biological E.
      • 2.4.1 Business Overview
      • 2.4.2 Paclitaxel Injection Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Biological E. Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Taj Accura
      • 2.5.1 Business Overview
      • 2.5.2 Paclitaxel Injection Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Taj Accura Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Khandelwal Laboratories
      • 2.6.1 Business Overview
      • 2.6.2 Paclitaxel Injection Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Khandelwal Laboratories Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Luye Pharma
      • 2.7.1 Business Overview
      • 2.7.2 Paclitaxel Injection Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Luye Pharma Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Beijing Youcare
      • 2.8.1 Business Overview
      • 2.8.2 Paclitaxel Injection Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Beijing Youcare Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Beijing Union
      • 2.9.1 Business Overview
      • 2.9.2 Paclitaxel Injection Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Beijing Union Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 Haiyao
      • 2.10.1 Business Overview
      • 2.10.2 Paclitaxel Injection Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Haiyao Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 Chuntch
      • 2.11.1 Business Overview
      • 2.11.2 Paclitaxel Injection Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 Chuntch Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Paclitaxel Injection Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Paclitaxel Injection Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Paclitaxel Injection Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Paclitaxel Injection Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Paclitaxel Injection Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Paclitaxel Injection Market Analysis by Regions

    • 4.1 Global Paclitaxel Injection Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Paclitaxel Injection Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Paclitaxel Injection Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Paclitaxel Injection Sales and Growth Rate (2014-2019)
    • 4.3 Europe Paclitaxel Injection Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Paclitaxel Injection Sales and Growth Rate (2014-2019)
    • 4.5 South America Paclitaxel Injection Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Paclitaxel Injection Sales and Growth Rate (2014-2019)

    5 North America Paclitaxel Injection by Country

    • 5.1 North America Paclitaxel Injection Sales, Revenue and Market Share by Country
      • 5.1.1 North America Paclitaxel Injection Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Paclitaxel Injection Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Paclitaxel Injection Sales and Growth Rate (2014-2019)
    • 5.3 Canada Paclitaxel Injection Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Paclitaxel Injection Sales and Growth Rate (2014-2019)

    6 Europe Paclitaxel Injection by Country

    • 6.1 Europe Paclitaxel Injection Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Paclitaxel Injection Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Paclitaxel Injection Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Paclitaxel Injection Sales and Growth Rate (2014-2019)
    • 6.3 UK Paclitaxel Injection Sales and Growth Rate (2014-2019)
    • 6.4 France Paclitaxel Injection Sales and Growth Rate (2014-2019)
    • 6.5 Russia Paclitaxel Injection Sales and Growth Rate (2014-2019)
    • 6.6 Italy Paclitaxel Injection Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Paclitaxel Injection by Country

    • 7.1 Asia-Pacific Paclitaxel Injection Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Paclitaxel Injection Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Paclitaxel Injection Revenue and Market Share by Country (2014-2019)
    • 7.2 China Paclitaxel Injection Sales and Growth Rate (2014-2019)
    • 7.3 Japan Paclitaxel Injection Sales and Growth Rate (2014-2019)
    • 7.4 Korea Paclitaxel Injection Sales and Growth Rate (2014-2019)
    • 7.5 India Paclitaxel Injection Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Paclitaxel Injection Sales and Growth Rate (2014-2019)

    8 South America Paclitaxel Injection by Country

    • 8.1 South America Paclitaxel Injection Sales, Revenue and Market Share by Country
      • 8.1.1 South America Paclitaxel Injection Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Paclitaxel Injection Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Paclitaxel Injection Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Paclitaxel Injection Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Paclitaxel Injection Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Paclitaxel Injection by Countries

    • 9.1 Middle East and Africa Paclitaxel Injection Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Paclitaxel Injection Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Paclitaxel Injection Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Paclitaxel Injection Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Paclitaxel Injection Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Paclitaxel Injection Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Paclitaxel Injection Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Paclitaxel Injection Sales and Growth Rate (2014-2019)

    10 Global Paclitaxel Injection Market Segment by Type

    • 10.1 Global Paclitaxel Injection Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Paclitaxel Injection Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Paclitaxel Injection Revenue and Market Share by Type (2014-2019)
    • 10.2 Drug Strength Sales Growth and Price
      • 10.2.1 Global Drug Strength Sales Growth (2014-2019)
      • 10.2.2 Global Drug Strength Price (2014-2019)
    • 10.3 Raw meterial Paclitaxel API source Sales Growth and Price
      • 10.3.1 Global Raw meterial Paclitaxel API source Sales Growth (2014-2019)
      • 10.3.2 Global Raw meterial Paclitaxel API source Price (2014-2019)

    11 Global Paclitaxel Injection Market Segment by Application

    • 11.1 Global Paclitaxel Injection Sales Market Share by Application (2014-2019)
    • 11.2 Ovarian cancer Sales Growth (2014-2019)
    • 11.3 Breast cancer Sales Growth (2014-2019)
    • 11.4 Cervical cancer Sales Growth (2014-2019)
    • 11.5 Pancreatic cancer Sales Growth (2014-2019)
    • 11.6 Other Sales Growth (2014-2019)

    12 Paclitaxel Injection Market Forecast (2019-2024)

    • 12.1 Global Paclitaxel Injection Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Paclitaxel Injection Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Paclitaxel Injection Market Forecast (2019-2024)
      • 12.2.2 Europe Paclitaxel Injection Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Paclitaxel Injection Market Forecast (2019-2024)
      • 12.2.4 South America Paclitaxel Injection Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Paclitaxel Injection Market Forecast (2019-2024)
    • 12.3 Paclitaxel Injection Market Forecast by Type (2019-2024)
      • 12.3.1 Global Paclitaxel Injection Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Paclitaxel Injection Market Share Forecast by Type (2019-2024)
    • 12.4 Paclitaxel Injection Market Forecast by Application (2019-2024)
      • 12.4.1 Global Paclitaxel Injection Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Paclitaxel Injection Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Summary:
      Get latest Market Research Reports on Paclitaxel Injection . Industry analysis & Market Report on Paclitaxel Injection is a syndicated market report, published as Global Paclitaxel Injection Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Paclitaxel Injection market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$3,480.00
      		$5,220.00
      		$6,960.00
      		2,794.44
      		4,191.66
      		5,588.88
      		3,253.80
      		4,880.70
      		6,507.60
      		539,852.40
      		809,778.60
      		1,079,704.80
      		290,058.00
      		435,087.00
      		580,116.00
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo